• 1. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 4. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 5. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527

Recent Advances in the Study of Methyl 4-methyl-5-oxo-4,5-dihydropyrazine-2-carboxylate (CAS: 1416447-68-1)

Methyl 4-methyl-5-oxo-4,5-dihydropyrazine-2-carboxylate (CAS: 1416447-68-1) is a pyrazine derivative that has garnered significant attention in the field of chemical biology and medicinal chemistry due to its potential applications in drug discovery and development. Recent studies have explored its synthesis, biological activity, and potential therapeutic uses, positioning it as a promising scaffold for novel pharmacophores.

The compound's unique structure, featuring a pyrazine core with a methyl ester and a keto group, enables diverse chemical modifications, making it a versatile intermediate in organic synthesis. Researchers have recently developed efficient synthetic routes to produce this compound with high yield and purity, which is critical for its application in high-throughput screening and structure-activity relationship (SAR) studies.

In a 2023 study published in the Journal of Medicinal Chemistry, methyl 4-methyl-5-oxo-4,5-dihydropyrazine-2-carboxylate was identified as a key intermediate in the synthesis of novel kinase inhibitors. The study demonstrated that derivatives of this compound exhibited potent inhibitory activity against several tyrosine kinases implicated in cancer progression, suggesting its potential as a lead compound for anticancer drug development.

Another recent investigation, reported in Bioorganic & Medicinal Chemistry Letters, highlighted the compound's role in the design of antimicrobial agents. Researchers synthesized a series of analogs and evaluated their efficacy against drug-resistant bacterial strains. The results indicated that certain derivatives displayed promising antibacterial activity, particularly against Gram-positive pathogens, with minimal cytotoxicity to mammalian cells.

Beyond its therapeutic potential, methyl 4-methyl-5-oxo-4,5-dihydropyrazine-2-carboxylate has also been explored for its utility in chemical biology. A 2024 study utilized this compound as a building block for the development of fluorescent probes targeting specific cellular enzymes. These probes enabled real-time monitoring of enzymatic activity in live cells, providing valuable insights into disease mechanisms and facilitating drug screening efforts.

Despite these advancements, challenges remain in optimizing the pharmacokinetic properties of derivatives derived from this scaffold. Recent computational studies have employed molecular docking and dynamics simulations to predict binding modes and improve drug-like characteristics, offering a roadmap for future structural modifications.

In conclusion, methyl 4-methyl-5-oxo-4,5-dihydropyrazine-2-carboxylate (CAS: 1416447-68-1) represents a versatile and promising compound in chemical biology and drug discovery. Ongoing research continues to uncover its potential across various therapeutic areas, from oncology to infectious diseases, underscoring its importance in modern medicinal chemistry.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)